These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22871426)

  • 1. Monitoring the dissolution of Active Pharmaceutical Ingredient and TPGS in real time via IR spectroscopy during the manufacturing of liquid dosage formulation.
    Šašić S; Palm AS; Tang D
    J Pharm Biomed Anal; 2012 Nov; 70():273-9. PubMed ID: 22871426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-line ATR-UV and Raman Spectroscopy for Monitoring API Dissolution Process During Liquid-Filled Soft-Gelatin Capsule Manufacturing.
    Wan B; Zordan CA; Lu X; McGeorge G
    AAPS PharmSciTech; 2016 Oct; 17(5):1173-81. PubMed ID: 26604007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tabletability assessment of conventional formulations containing Vitamin E tocopheryl polyethylene glycol succinate.
    Jin F; Tatavarti A
    Int J Pharm; 2010 Apr; 389(1-2):58-65. PubMed ID: 20083178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
    Zhang Z; Chen Y; Deng J; Jia X; Zhou J; Lv H
    Int J Pharm; 2014 Apr; 465(1-2):306-16. PubMed ID: 24456672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Extrusion Spheronization Approach to Enable a High Drug Load Formulation of a Poorly Soluble Drug with a Low Melting Surfactant.
    Tatavarti A; Kesisoglou F
    J Pharm Sci; 2015 Nov; 104(11):3752-3759. PubMed ID: 26205160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of excipients on solubility and dissolution of pharmaceuticals.
    Paus R; Prudic A; Ji Y
    Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supersaturated dissolution data and their interpretation: the TPGS-carbamazepine model case.
    Charkoftaki G; Dokoumetzidis A; Valsami G; Macheras P
    J Pharm Pharmacol; 2011 Mar; 63(3):352-61. PubMed ID: 21749382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
    Mu L; Teo MM; Ning HZ; Tan CS; Feng SS
    J Control Release; 2005 Apr; 103(3):565-75. PubMed ID: 15820404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100.
    Goddeeris C; Willems T; Houthoofd K; Martens JA; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Nov; 70(3):861-8. PubMed ID: 18691650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etodolac-liquid-filled dispersion into hard gelatin capsules: an approach to improve dissolution and stability of etodolac formulation.
    Barakat NS
    Drug Dev Ind Pharm; 2006 Aug; 32(7):865-76. PubMed ID: 16908424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of physical factors on the accuracy of calibration models for NIR spectroscopy.
    Blanco M; Peguero A
    J Pharm Biomed Anal; 2010 May; 52(1):59-65. PubMed ID: 20044229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAT for tableting: inline monitoring of API and excipients via NIR spectroscopy.
    Wahl PR; Fruhmann G; Sacher S; Straka G; Sowinski S; Khinast JG
    Eur J Pharm Biopharm; 2014 Jul; 87(2):271-8. PubMed ID: 24705126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology.
    Moneghini M; De Zordi N; Solinas D; Macchiavelli S; Princivalle F
    Future Med Chem; 2010 Feb; 2(2):237-46. PubMed ID: 21426191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of curcumin nanocrystal: physical aspects.
    Rachmawati H; Al Shaal L; Müller RH; Keck CM
    J Pharm Sci; 2013 Jan; 102(1):204-14. PubMed ID: 23047816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An innovative floating gastro retentive dosage system: formulation and in vitro evaluation.
    Sauzet C; Claeys-Bruno M; Nicolas M; Kister J; Piccerelle P; Prinderre P
    Int J Pharm; 2009 Aug; 378(1-2):23-9. PubMed ID: 19465095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing challenges with solid dosage formulations containing vitamin E TPGS.
    Pandey P; Sinko PD; Bindra DS; Hamey R; Gour S; Vema-Varapu C
    Pharm Dev Technol; 2013 Feb; 18(1):296-304. PubMed ID: 23136832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time endpoint monitoring and determination for a pharmaceutical salt formation process with in-line FT-IR spectroscopy.
    Lin Z; Zhou L; Mahajan A; Song S; Wang T; Ge Z; Ellison D
    J Pharm Biomed Anal; 2006 Apr; 41(1):99-104. PubMed ID: 16321495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excipient variability and its impact on dosage form functionality.
    Dave VS; Saoji SD; Raut NA; Haware RV
    J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near InfraRed Spectroscopy homogeneity evaluation of complex powder blends in a small-scale pharmaceutical preformulation process, a real-life application.
    Storme-Paris I; Clarot I; Esposito S; Chaumeil JC; Nicolas A; Brion F; Rieutord A; Chaminade P
    Eur J Pharm Biopharm; 2009 May; 72(1):189-98. PubMed ID: 19059338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.